Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Parkinson's Disease

Free Subscription Articles published in Neurosci Lett Retrieve available abstracts of 56 articles: HTML format

Single Articles

October 2025
1. TOGAWA K, Matsumoto S, Deng L, Jin M, et al
   DOPAnization of alpha-synuclein exacerbates dopaminergic neurodegeneration in the substantia nigra.
   Neurosci Lett. 2025;865:138354.
   PubMed     Abstract available
   
   
   
2. ZHGENTI N, Bakuradze E, Bibilashvili O, Koshoridze N, et al
   The role of BDNF/PI3K/AKT/Nrf2 signaling in nicotine's protective effects against MPTP-induced Parkinson's disease.
   Neurosci Lett. 2025;868:138412.
   PubMed     Abstract available
   
   
   August 2025
3. WANG J, Hou J, Du M, Hou X, et al
   The mechanism of alpha-lipoic acid regulating dopaminergic neuronal damage in Parkinson's disease through the Nrf2/HMOX1 pathway.
   Neurosci Lett. 2025 Aug 3:138338. doi: 10.1016/j.neulet.2025.138338.
   PubMed     Abstract available
   
   
   July 2025
4. DENG X, Zheng W, Xu H, Yang Y, et al
   Genetic analysis of TMEM230 variants in Han Chinese patients with Parkinson's disease.
   Neurosci Lett. 2025 Jul 29:138334. doi: 10.1016/j.neulet.2025.138334.
   PubMed     Abstract available
   
   
   May 2025
5. SUGIYAMA K, Kuroiwa M, Shuto T, Hwang S, et al
   Subregion-specific suppression of dopamine D1 receptor expression prevents L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease.
   Neurosci Lett. 2025 May 25:138273. doi: 10.1016/j.neulet.2025.138273.
   PubMed     Abstract available
   
   
   
6. CORTES-ALTAMIRANO JL, Alfaro-Rodriguez A, Morraz-Varela A, Reyes-Long S, et al
   Changes in gene expression of D2 and D5 receptors in the thalamus and midbrain caused by a persistent painful stimulus in Parkinsonian rats.
   Neurosci Lett. 2025;859-861:138270.
   PubMed     Abstract available
   
   
   January 2025
7. ORTEGA A, Laville A, Padilla-Orozco M, Parrado Y, et al
   Cortical beta oscillation in brain slices of hemi parkinsonian mice.
   Neurosci Lett. 2025;849:138128.
   PubMed     Abstract available
   
   
   October 2024
8. ZHANG J, Dong M, Li Z, Li Z, et al
   Association of plasma neurofilament light chain and Lipoprotein-related phospholipase A2 with motor subtypes of Parkinson's disease.
   Neurosci Lett. 2024 Oct 16:138011. doi: 10.1016/j.neulet.2024.138011.
   PubMed     Abstract available
   
   
   
9. VILLAMAR-FLORES CI, Rodriguez-Violante M, Abundes-Corona A, Alatriste-Booth V, et al
   Association between alterations in sleep spindles and cognitive decline in persons with Parkinson's disease.
   Neurosci Lett. 2024;842:138006.
   PubMed     Abstract available
   
   
   September 2024
10. BAGWELL E, Shin M, Henkel N, Migliaccio D, et al
    1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated adult zebrafish as a model for Parkinson's Disease.
    Neurosci Lett. 2024;842:137991.
    PubMed     Abstract available
    
    
    
11. JIANG M, Liu Y, Cao Y, Liu Y, et al
    Auxiliary diagnostic method of Parkinson's disease based on eye movement analysis in a virtual reality environment.
    Neurosci Lett. 2024 Sep 2:137956. doi: 10.1016/j.neulet.2024.137956.
    PubMed     Abstract available
    
    
    August 2024
12. ZHANG W, Peng H, Yang D, Song G, et al
    Absence of motor impairments or pathological changes in TMEM230 knockout rats.
    Neurosci Lett. 2024;837:137921.
    PubMed     Abstract available
    
    
    
13. FAN X, Tang Y, Wei Z, Shi F, et al
    Mitochondrial dysfunction and NDUFS3: Insights from a PINK1(B9) Drosophila model in Parkinson's disease pathogenesis.
    Neurosci Lett. 2024 Aug 3:137917. doi: 10.1016/j.neulet.2024.137917.
    PubMed     Abstract available
    
    
    July 2024
14. CHEN J, Meng Q, Zhang Y, Liang Y, et al
    TrueTH: A user-friendly deep learning approach for robust dopaminergic neuron detection.
    Neurosci Lett. 2024;836:137871.
    PubMed     Abstract available
    
    
    
15. HE Q, Zhou Y, Jin J, Tian Q, et al
    Association between NEK1 gene polymorphisms and the potential risk of sporadic Parkinson's disease in the Chinese Northern Han population: A case-control study.
    Neurosci Lett. 2024 Jul 18:137913. doi: 10.1016/j.neulet.2024.137913.
    PubMed     Abstract available
    
    
    June 2024
16. MENG Q, Chen J, Liang Y, Zhang X, et al
    miR-142-3p alleviates neuronal apoptosis in Parkinson's disease via negatively regulating C9orf72.
    Neurosci Lett. 2024 Jun 26:137887. doi: 10.1016/j.neulet.2024.137887.
    PubMed     Abstract available
    
    
    
17. MARANO M, Altavista MC, Cassetta E, Brusa L, et al
    The influence of sex on non-motor wearing-off in Parkinson's disease: A WORK-PD post-hoc study.
    Neurosci Lett. 2024 Jun 7:137850. doi: 10.1016/j.neulet.2024.137850.
    PubMed     Abstract available
    
    
    April 2024
18. ZAMEER F, Jain P, Khan K, Pramod Kumar P, et al
    Unraveling the regulatory landscape of Parkinson disease: A molecular symphony of miRNAs, transcription factors, and high-risk genes.
    Neurosci Lett. 2024 Apr 25:137792. doi: 10.1016/j.neulet.2024.137792.
    PubMed     Abstract available
    
    
    March 2024
19. LI Z, Liu J, Miao X, Ge S, et al
    Reorganization of structural brain networks in Parkinson's disease with postural instability/gait difficulty.
    Neurosci Lett. 2024 Mar 19:137736. doi: 10.1016/j.neulet.2024.137736.
    PubMed     Abstract available
    
    
    February 2024
20. SARKAR S, Biswas A, Ansari S, Choudhury S, et al
    Association of dopamine receptor D3 polymorphism with Levodopa-induced Dyskinesia: A study on Parkinson's disease patients from India.
    Neurosci Lett. 2024;825:137706.
    PubMed     Abstract available
    
    
    
21. ADLER CH, Serrano GE, Shill HA, Driver-Dunckley E, et al
    Symmetry of synuclein density in autopsied Parkinson's disease submandibular glands.
    Neurosci Lett. 2024;825:137702.
    PubMed     Abstract available
    
    
    
22. TAKIZAWA S, Ohuchi K, Fujimaki A, Ito T, et al
    Effects of alpha7 nicotinic acetylcholine receptor agonist against alpha-synuclein-induced neurotoxicity.
    Neurosci Lett. 2024;823:137654.
    PubMed     Abstract available
    
    
    
23. CAKIR M, Sacmaci H
    The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
    PubMed     Abstract available
    
    
    January 2024
24. LIU H, Gong Z, Li Z, Ye T, et al
    Distribution, connection and function of ALDH1A1(+)/TH(+) neurons in substantia nigra pars reticulata of mouse.
    Neurosci Lett. 2024;818:137555.
    PubMed     Abstract available
    
    
    December 2023
25. HU Q, Xu L, Liu X, Wang Y, et al
    Adenosine A(2A) receptor antagonist KW6002 protects against A53T mutant alpha-synuclein-induced brain damage and neuronal apoptosis in Parkinson's disease mice by restoring autophagic flux.
    Neurosci Lett. 2023 Dec 27:137610. doi: 10.1016/j.neulet.2023.137610.
    PubMed     Abstract available
    
    
    
26. HUANG W, Wang Y, Huang W
    Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
    Neurosci Lett. 2023 Dec 22:137608. doi: 10.1016/j.neulet.2023.137608.
    PubMed     Abstract available
    
    
    
27. RAJAN S, Sood A, Jain R, Kamatham PT, et al
    Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease.
    Neurosci Lett. 2023;820:137596.
    PubMed     Abstract available
    
    
    November 2023
28. BILISTER EGILMEZ C, Azak Pazarlar B, Alper Erdogan M, Erbas O, et al
    Neuroprotective effect of dexpanthenol on rotenone-induced Parkinson's disease model in rats.
    Neurosci Lett. 2023 Nov 29:137575. doi: 10.1016/j.neulet.2023.137575.
    PubMed     Abstract available
    
    
    
29. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    PubMed     Abstract available
    
    
    
30. SINGH A, Panhelainen A, Voutilainen MH
    Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration.
    Neurosci Lett. 2023;816:137510.
    PubMed     Abstract available
    
    
    
31. PAN Y, Zong Q, Li G, Wu Z, et al
    Nuclear localization of alpha-synuclein induces anxiety-like behavior in mice by decreasing hippocampal neurogenesis and pathologically affecting amygdala circuits.
    Neurosci Lett. 2023;816:137490.
    PubMed     Abstract available
    
    
    October 2023
32. MONAGHAN AS, Hooyman A, Dibble LE, Mehta SH, et al
    Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson's Disease at Fall-Risk.
    Neurosci Lett. 2023;817:137517.
    PubMed     Abstract available
    
    
    September 2023
33. STATZ M, Schleuter F, Weber H, Kober M, et al
    Subthalamic nucleus deep brain stimulation does not alter growth factor expression in a rat model of stable dopaminergic deficiency.
    Neurosci Lett. 2023;814:137459.
    PubMed     Abstract available
    
    
    
34. GENG X, Zou Y, Li J, Li S, et al
    Mesenchymal stem cell exosomes rich in miR-23b-3p affect the Wnt signaling pathway and promote neuronal autophagy to alleviate PD symptoms.
    Neurosci Lett. 2023;814:137437.
    PubMed     Abstract available
    
    
    August 2023
35. HEO EJ, Lee Y, Hyung Seo M, Yeo S, et al
    Association between SGK1 and alpha-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model.
    Neurosci Lett. 2023 Aug 25:137464. doi: 10.1016/j.neulet.2023.137464.
    PubMed     Abstract available
    
    
    
36. KAPLAN ALGIN A, Tomruk C, Gozde Aslan C, Saban Akkurt S, et al
    Effects of ozone treatment to the levels of neurodegeneration biomarkers after rotenone induced rat model of Parkinson's disease.
    Neurosci Lett. 2023;814:137448.
    PubMed     Abstract available
    
    
    
37. HE P, Gao Y, Shi L, Li Y, et al
    Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.
    Neurosci Lett. 2023 Aug 8:137435. doi: 10.1016/j.neulet.2023.137435.
    PubMed     Abstract available
    
    
    
38. TAN Z, Lin Y, Zhou M, Guo W, et al
    Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China.
    Neurosci Lett. 2023 Aug 4:137426. doi: 10.1016/j.neulet.2023.137426.
    PubMed     Abstract available
    
    
    July 2023
39. TIAN Q, Sun X, Li C, Yang Y, et al
    CD33 polymorphisms and Parkinson's disease Parkinson's disease in northern Chinese Han population: A case-control study.
    Neurosci Lett. 2023;812:137400.
    PubMed     Abstract available
    
    
    
40. LI Y, Li F, Liu X, Zu J, et al
    Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson's disease.
    Neurosci Lett. 2023 Jul 10:137394. doi: 10.1016/j.neulet.2023.137394.
    PubMed     Abstract available
    
    
    
41. JIN H, Shen H, Liu C, Wang L, et al
    Decreased Serum BDNF Contributes to the Onset of REM Sleep Behavior Disorder in Parkinson's Disease Patients.
    Neurosci Lett. 2023 Jul 7:137380. doi: 10.1016/j.neulet.2023.137380.
    PubMed     Abstract available
    
    
    June 2023
42. HWAN SHIN J, Ah Shin D, Young Lee C, Jin Chang H, et al
    Inability to suppress head rotation during the saccade test as a clinical biomarker for cognitive dysfunction in Parkinson's disease.
    Neurosci Lett. 2023 Jun 22:137356. doi: 10.1016/j.neulet.2023.137356.
    PubMed     Abstract available
    
    
    
43. ZHENG Q, Ma P, Yang P, Zhai S, et al
    Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson's disease.
    Neurosci Lett. 2023 Jun 10:137346. doi: 10.1016/j.neulet.2023.137346.
    PubMed     Abstract available
    
    
    May 2023
44. WANG X, Wei W, Bai Y, Shen Y, et al
    Intrinsic Brain Activity Alterations in Patients With Parkinson's disease.
    Neurosci Lett. 2023 May 15:137298. doi: 10.1016/j.neulet.2023.137298.
    PubMed     Abstract available
    
    
    April 2023
45. ZHANG X, Zhong X, Wang L, Li H, et al
    Effects of soluble TREM2 on motor progression in Parkinson's disease.
    Neurosci Lett. 2023 Apr 25:137277. doi: 10.1016/j.neulet.2023.137277.
    PubMed     Abstract available
    
    
    
46. ZHANG X, Li L, Qi L, Fu Y, et al
    Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.
    Neurosci Lett. 2023 Apr 13:137249. doi: 10.1016/j.neulet.2023.137249.
    PubMed     Abstract available
    
    
    
47. SHIDA TKF, de Oliveira CEN, da Silva Fragoso de Campos D, Los Angeles E, et al
    Effect of freezing of gait and dopaminergic medication in the biomechanics of lower limbs in the gait of patients with Parkinson's disease compared to neurologically healthy.
    Neurosci Lett. 2023;806:137250.
    PubMed     Abstract available
    
    
    
48. MURAKAMI Y, Nishijima H, Nakamura T, Furukawa T, et al
    Altered amantadine effects after repetitive treatment for l-dopa-induced involuntary movements in a rat model of Parkinson's disease.
    Neurosci Lett. 2023;806:137248.
    PubMed     Abstract available
    
    
    
49. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    PubMed     Abstract available
    
    
    
50. MA C, Wei X, Wang F, Zhang T, et al
    Tumor necrosis factor alpha-induced protein 3 mediates inflammation and neuronal autophagy in Parkinson's disease via the NFkappaB and mTOR pathways.
    Neurosci Lett. 2023 Apr 3:137223. doi: 10.1016/j.neulet.2023.137223.
    PubMed     Abstract available
    
    
    
51. MORRISON S, Reilly N, Schussler E, Kerr G, et al
    The effect of standing posture on amplitude and variability of postural tremor in Parkinson's disease.
    Neurosci Lett. 2023 Apr 3:137220. doi: 10.1016/j.neulet.2023.137220.
    PubMed     Abstract available
    
    
    
52. YUAN M, Du N, Song Z
    Primary motor area-related injury of anterior central gyrus in Parkinson's disease with dyskinesia: a study based on MRS and Q-Space.
    Neurosci Lett. 2023 Apr 3:137224. doi: 10.1016/j.neulet.2023.137224.
    PubMed     Abstract available
    
    
    March 2023
53. GOMEZ-MARTIN A, Fuentes JM, Jordan J, Galindo MF, et al
    Detection of rare Genetic Variations in the promoter regions of the ATG16L gene in Parkinson's patients.
    Neurosci Lett. 2023 Mar 21:137195. doi: 10.1016/j.neulet.2023.137195.
    PubMed     Abstract available
    
    
    
54. LI W, Pan X, Li M, Ling L, et al
    Impact of age on the rotenone-induced sporadic Parkinson's disease model using Drosophila melanogaster.
    Neurosci Lett. 2023 Mar 13:137187. doi: 10.1016/j.neulet.2023.137187.
    PubMed     Abstract available
    
    
    February 2023
55. OMAR AHMAD S, Longhurst J, Stiles D, Downard L, et al
    A meta-analysis of exercise intervention and the effect on Parkinson's Disease Symptoms.
    Neurosci Lett. 2023 Feb 28:137162. doi: 10.1016/j.neulet.2023.137162.
    PubMed     Abstract available
    
    
    
56. CARNEY AE, Clarke C, Pratt WE
    Administration of neuropeptide Y into the rat nucleus accumbens shell, but not core, attenuates the motivational impairment from systemic dopamine receptor antagonism by alpha-flupenthixol.
    Neurosci Lett. 2023;797:137069.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.